The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months
Aman U. Buzdar(The University of Texas MD Anderson Cancer Center)
Cited by 59
Abstract
Related Papers
No related papers found
Powered by citation graph analysis